Bala Gur Dedeoglu

Prof. Dr. Bala Gur Dedeoglu

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
NONuri Ozturk
Nuri Ozturk
EEEsra Erdal
Esra Erdal
MMMine Mumcuoglu
Mine Mumcuoglu
KAKamil C. Akcali
Kamil C. Akcali
OYOzden Yalcin
Ozden Yalcin
MOMehmet Ozturk
Mehmet Ozturk
Tumor cells have the capacity to proliferate indefinitely that is qualified as replicative immortality. This ability contrasts with the intrinsic control of the number of cell divisions in human somatic tissues by a mechanism called replicative senescence. Replicative immortality is acquired by inactivation of p53 and p16INK4a genes and reactivation of hTERT gene expression. It is unknown whether the cancer cell replicative immortality is reversible. Here, we show the spontaneous induction of replicative senescence in p53-and p16INK4a-deficient hepatocellular carcinoma cells. This phenomenon is characterized with hTERT repression, telomere shortening, senescence arrest, and tumor suppression. SIP1 gene (ZFHX1B) is partly responsible for replicative senescence, because short hairpin RNA-mediated SIP1 inactivation released hTERT repression and rescued clonal hepatocellular carcinoma cells from senescence arrest.

20 December 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AAAlp Aydos
Alp Aydos
AGAykut Gurel
Aykut Gurel
YIYasemin Oztemur Islakoglu
Yasemin Oztemur Islakoglu
SNSenem Noyan
Senem Noyan
BGBagdagul Gokce
Bagdagul Gokce
BDBala Gur Dedeoglu
Bala Gur Dedeoglu
Polycystic ovary syndrome (PCOS) is a metabolic and endocrine disorder which affects women of reproductive age with prevalence of 8–18%. The oocyte within the follicle is surrounded by cumulus cells (CCs), which connect with mural granulosa cells (MGCs) that are responsible for secreting steroid hormones. The main aim of this study is comparing gene expression profiles of MGCs and CCs in PCOS and control samples to identify PCOS-specific differentially expressed genes (DEGs). In this study, two microarray databases were searched for mRNA expression microarray studies performed with CCs and MGCs obtained from PCOS patients and control samples. Three independent studies were selected to be integrated with naive meta-analysis since raw meta-data from these studies were found to be highly correlated. DEGs in these somatic cells were identified for PCOS and control groups. This study enabled us to reveal dysregulation in MAPK (mitogen activated protein kinase), insulin and Wnt signaling pathways between CCs and MGCs in PCOS. The meta-analysis results together with qRT-PCR validations provide evidence that molecular signaling is dysregulated through MGCs and CCs in PCOS, which is important for follicle and oocyte maturation and may contribute to the pathogenesis of the syndrome.

1 July 2021 in Cellular Signalling
Verified
Journal Article
Closed access
SNSenem Noyan
Senem Noyan
AOAyşe Andac Ozketen
Ayşe Andac Ozketen
HGHakan Gurdal
Hakan Gurdal
BDBala Gur Dedeoglu
Bala Gur Dedeoglu

1 December 2017 in Leukemia Research
Verified
Journal Article
Closed access
HOHakan Ozdogan
Hakan Ozdogan
BDBala Gur Dedeoglu
Bala Gur Dedeoglu
YIYasemin Oztemur Islakoglu
Yasemin Oztemur Islakoglu
AAAlp Aydos
Alp Aydos
SKSevil Kose
Sevil Kose
OIOsman Ilhan
Osman Ilhan

1 December 2007 in Hematology
Verified
Journal Article
Open access
YBYusuf Baran
Yusuf Baran
BDBala Gur Dedeoglu
Bala Gur Dedeoglu
PKPelin Kaya
Pelin Kaya
AUAli Uğur Ural
Ali Uğur Ural
FAFerit Avcu
Ferit Avcu
UGUfuk Gündüz
Ufuk Gündüz
The major problem in the treatment of acute myeloid leukemia (AML) patients results from multidrug resistance to administered anticancer agents. Drug resistance proteins, MDR1 and MRP1, which work as drug efflux pumps, can mediate the multidrug resistance of human leukemia cells. In this study, the mechanisms of resistance to doxorubicin-induced cell death in human HL60 AML cells were examined. Continuous exposure of cells to step-wise increasing concentrations of doxorubicin resulted in the selection of HL60/DOX cells, which expressed about 10.7-fold resistance as compared to parental sensitive cells. The expression analyses of MRP1 and MDR1 drug efflux proteins in doxorubicin-sensitive and -resistant HL60 cells revealed that there was an upregulation of MRP1 gene in HL60/DOX cells as compared to parental sensitive cells. On the other hand, while there was no expression of MDR1 gene in parental cells, the expression of MDR1 gene was upregulated in HL60/DOX cells. HL60/DOX cells also showed cross-resistance to cytosine arabinoside (Ara-c). This resistance was reversed by a combination therapy of Ara-c and cyclosporine A. However, the expression levels of CD15 and CD16 surface markers were significantly decreased in HL60/DOX cells.

22 April 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SNSenem Noyan
Senem Noyan
HGHakan Gurdal
Hakan Gurdal
BDBala Gur Dedeoglu
Bala Gur Dedeoglu
MiRNAs may play effective roles in breast cancer so modulating their expression levels could have therapeutic benefits. Recent studies have found the combination of miRNA-based therapeutics with conventional drugs as promising. This study aimed to find drug-responsive miRNAs, and explore their anticancer activities in HER2+ breast cancer cells and regulatory role in the trastuzumab response. qRT-PCR-array analysis was performed with effective concentrations of tamoxifen and trastuzumab treated BT-474, SK-BR-3 and MCF-7 cells. Motility and invasion analyses were performed with wound healing and xCELLigence impedance-based assays respectively. Viability of cells following mimic transfection and drug treatment was assessed by WST-1 assay. Western blot analysis was used to assess miR-770-5p regulation of proteins and their phosphorylated forms. The clinical relevance of miR-770-5p was examined by TCGA data analysis. The qRT-PCR-array results indicated that miR-770-5p was responsive in a drug and cell line independent manner. Overexpression of miR-770-5p inhibited the motility and cell invasion through regulation of AKT and ERK proteins. Additionally, miR-770-5p potentiated the effectiveness of trastuzumab. Thus, regulating the expression level of miR-770-5p in combination with trastuzumab treatment may simultaneously inhibit the downstream elements of PI3K and MAPK signalling, thereby blocking the proliferation, motility and invasion capacities of HER2+ breast cancer cells.